These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 19096817)
21. Long-term cognitive effects of glucocorticoid excess in Cushing's syndrome. Forget H; Lacroix A; Bourdeau I; Cohen H Psychoneuroendocrinology; 2016 Mar; 65():26-33. PubMed ID: 26708069 [TBL] [Abstract][Full Text] [Related]
22. Familial/sporadic glucocorticoid resistance syndrome and hypertension. Kino T; Vottero A; Charmandari E; Chrousos GP Ann N Y Acad Sci; 2002 Sep; 970():101-11. PubMed ID: 12381545 [TBL] [Abstract][Full Text] [Related]
23. Pathophysiology of Glucocorticoid Signaling. Vitellius G; Trabado S; Bouligand J; Delemer B; Lombès M Ann Endocrinol (Paris); 2018 Jun; 79(3):98-106. PubMed ID: 29685454 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of iatrogenic Cushing syndrome: questions of glucocorticoid withdrawal]. Igaz P; Rácz K; Tóth M; Gláz E; Tulassay Z Orv Hetil; 2007 Feb; 148(5):195-202. PubMed ID: 17344139 [TBL] [Abstract][Full Text] [Related]
34. Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease. Morton NM Mol Cell Endocrinol; 2010 Mar; 316(2):154-64. PubMed ID: 19804814 [TBL] [Abstract][Full Text] [Related]
37. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome. Masuzaki H; Flier JS Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456 [TBL] [Abstract][Full Text] [Related]
38. How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids. Ong SL; Whitworth JA Endocrinol Metab Clin North Am; 2011 Jun; 40(2):393-407, ix. PubMed ID: 21565674 [TBL] [Abstract][Full Text] [Related]